ClinicalTrials.Veeva

Menu

Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells) (EPC)

U

University of South Alabama (USA)

Status

Completed

Conditions

Type 2 Diabetes

Treatments

Behavioral: pre-bariatric weight loss program
Procedure: bariatric surgery

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after bariatric surgery.

Full description

Same as above

Enrollment

20 patients

Sex

All

Ages

19 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Type 2 Diabetes, Glucose > 200mg/dl, currently be ing treated with oral medications and HGA1c . 6.5, and BMI .35.

Exclusion criteria

  • Type 1 Diabetes

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

baratric surgery
Other group
Description:
surgery vs.weight loss program 6 months prior to bariatric surgery
Treatment:
Procedure: bariatric surgery
pre-bariatric weight loss program
Other group
Description:
weight loss program prior to bariatric surgery
Treatment:
Behavioral: pre-bariatric weight loss program

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems